HS
MGNX icon

HighVista Strategies’s MacroGenics MGNX Stock Holding History

HighVista Strategies’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-54,012
Closed -$867K – 91
2021
Q4 		$867K Hold
54,012
– – 0.69% 54
2021
Q3 		$1.13M Buy
54,012
+28,908
+115% +$696K 0.75% 45
2021
Q2 		$674K Sell
25,104
-13,118
-34% -$384K 0.48% 65
2021
Q1 		$1.22M Buy
38,222
+3,617
+10% +$87.8K 0.9% 18
2020
Q4 		$791K Buy
34,605
+16,461
+91% +$379K 0.51% 46
2020
Q3 		$457K Buy
+18,144
New +$495K 0.33% 58

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HighVista Strategies's MGNX Position: Q1 2022 in Review

HighVista Strategies sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 54,012 shares — an estimated $867K sold.

HighVista Strategies first reported a position in MGNX in Q3 2020 and held it in 6 quarters. The position peaked at $1.22M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • HighVista Strategies reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • HighVista Strategies sold 54,012 MacroGenics shares in Q1 2022, an estimated $867K.
  • HighVista Strategies first reported a position in MacroGenics in Q3 2020 and held it in 6 quarters.
  • HighVista Strategies's MacroGenics position peaked at $1.22M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on HighVista Strategies's 13F filing for Q1 2022, filed 16 May 2022.